# BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies

> Research article (JCO Precision Oncology, 2020) · cited 143× · AI/ML

**Wikidata**: [openalex:W3100720535](https://www.wikidata.org/wiki/openalex:W3100720535)  
**Source**: https://4ort.xyz/entity/boin12-bayesian-optimal-interval-phase-i-ii-trial-design-for-utility-based-dose-finding-in-immunotherapy-and-targeted-th